Alignment Healthcare (NASDAQ:ALHC) Insider Sells $303,344.38 in Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC) insider Christopher Joyce sold 16,187 shares of Alignment Healthcare stock in a transaction dated Monday, December 29th. The shares were sold at an average price of $18.74, for a total value of $303,344.38. Following the completion of the sale, the insider owned 307,699 shares of the company’s stock, valued at $5,766,279.26. The trade was a 5.00% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.

Alignment Healthcare Stock Up 1.6%

Alignment Healthcare stock traded up $0.30 during midday trading on Tuesday, hitting $19.24. 2,308,291 shares of the company’s stock were exchanged, compared to its average volume of 3,029,631. The company has a debt-to-equity ratio of 1.99, a quick ratio of 1.61 and a current ratio of 1.61. The company has a market cap of $3.85 billion, a PE ratio of -160.33 and a beta of 1.16. The firm has a 50-day moving average of $18.18 and a two-hundred day moving average of $16.19. Alignment Healthcare, Inc. has a 12 month low of $11.01 and a 12 month high of $21.06.

Alignment Healthcare (NASDAQ:ALHC) last posted its quarterly earnings results on Thursday, October 30th. The company reported $0.02 EPS for the quarter, beating the consensus estimate of ($0.01) by $0.03. Alignment Healthcare had a negative net margin of 0.57% and a negative return on equity of 16.23%. The business had revenue of $993.70 million during the quarter, compared to analyst estimates of $980.90 million. During the same quarter in the previous year, the business posted ($0.14) EPS. The company’s quarterly revenue was up 43.5% compared to the same quarter last year. As a group, analysts expect that Alignment Healthcare, Inc. will post -0.69 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Alignment Healthcare

Hedge funds and other institutional investors have recently made changes to their positions in the company. Larson Financial Group LLC acquired a new position in Alignment Healthcare in the third quarter valued at about $33,000. SBI Securities Co. Ltd. raised its stake in shares of Alignment Healthcare by 4,868.9% in the 2nd quarter. SBI Securities Co. Ltd. now owns 3,031 shares of the company’s stock valued at $42,000 after acquiring an additional 2,970 shares during the period. KBC Group NV purchased a new stake in shares of Alignment Healthcare in the 2nd quarter valued at approximately $44,000. Signaturefd LLC lifted its holdings in shares of Alignment Healthcare by 142.6% in the 2nd quarter. Signaturefd LLC now owns 3,768 shares of the company’s stock worth $53,000 after acquiring an additional 2,215 shares during the last quarter. Finally, Wilmington Savings Fund Society FSB purchased a new position in shares of Alignment Healthcare during the 3rd quarter worth approximately $53,000. Institutional investors and hedge funds own 86.19% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts recently weighed in on ALHC shares. Zacks Research cut Alignment Healthcare from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, October 28th. KeyCorp reiterated an “overweight” rating on shares of Alignment Healthcare in a report on Monday, November 24th. Wall Street Zen upgraded shares of Alignment Healthcare from a “hold” rating to a “buy” rating in a report on Saturday, November 8th. Barclays lifted their price objective on shares of Alignment Healthcare from $13.00 to $18.00 and gave the stock an “equal weight” rating in a research report on Friday, October 31st. Finally, JPMorgan Chase & Co. increased their target price on shares of Alignment Healthcare from $20.00 to $23.00 and gave the company an “overweight” rating in a research report on Wednesday, December 17th. One equities research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, three have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $20.35.

About Alignment Healthcare

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.